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A B S T R A C T
Neural networks are powerful tools used widely for building cancer prediction models from microarray data. We
review the most recently proposed models to highlight the roles of neural networks in predicting cancer from
gene expression data. We identified articles published between 2013–2018 in scientific databases using key-
words such as cancer classification, cancer analysis, cancer prediction, cancer clustering and microarray data.
Analyzing the studies reveals that neural network methods have been either used for filtering (data engineering)
the gene expressions in a prior step to prediction; predicting the existence of cancer, cancer type or the survi-
vability risk; or for clustering unlabeled samples. This paper also discusses some practical issues that can be
considered when building a neural network-based cancer prediction model. Results indicate that the function-
ality of the neural network determines its general architecture. However, the decision on the number of hidden
layers, neurons, hypermeters and learning algorithm is made using trail-and-error techniques.
1. Introduction
Microarray technology is one of the most widely used tools for
analyzing genetic diseases. Standardized microarray dataset consists of
thousands of gene expressions and a few hundred of samples. Each
expression measures the level of activity of genes within a given tissue
so comparing the genes expressed in abnormal cancerous tissues with
those in normal tissues gives a good insight into the disease pathology
and allows for better diagnosis and predictions for future samples.
The high dimensionality of the gene expression profiles is a crucial
issue when building a cancer predictive model. This problem affects the
accuracy of the model and increases the computational time [11,27].
Two general approaches have been suggested to reduce the di-
mensionality of the gene expressions and to overcome its consequent
problems. These are: (i) feature selection methods, which select the
most relevant discriminating features and eliminate the non-relevant
dependent features; and (ii) feature creation methods, which generate
new low dimensional features (codes) that best represent the original
high dimensional features (as indicated in [77]).
Neural networks are powerful machine learning methods that are
used widely to learn data representations (features) at multiple levels of
abstractions. These representations are useful for many applications
such as reconstruction, classification, clustering and recognition.
Predictive models such as cancer prediction models use the generated
features for classifying, clustering or applying statistical analysis on the
samples.
Based on our analysis of the most recent studies on cancer predic-
tion models, we categorize the current neural network methods ac-
cording to their functionality into: (i) filtering (preprocessing) methods,
(ii) predicting (classification) methods, and (iii) clustering methods.
Neural network filtering methods are used for extracting representa-
tions that best describe the gene expressions without any direct con-
sideration to the prediction goal, such as the networks used in [67,28].
Alternatively, predicting and clustering methods extract the re-
presentations that, respectively, maximize the prediction accuracy
[12,20,50] or best divide the genes or samples according to their mu-
tual similarities into groups respectively [81,83,9].
In this study, we review the most recent neural network-based
cancer prediction models by presenting the data preprocessing tools
and the adopted architectures. We also provide a brief discussion to
highlight some important issues that can be considered when building
new cancer prediction models. This work is distinguished from others
by presenting neural networks models that were specifically designed
for predicting cancer using gene expression data. Previous works such
as [48] focused on applications of deep learning in different bioinfor-
matic related fields. Deep learning applications in regulatory genomics
and biological image analysis was introduced in [3] which also presents
some practical points to start with deep architectures. Ravi et al. [60]
https://doi.org/10.1016/j.artmed.2019.01.006
Received 1 October 2017; Received in revised form 22 October 2018; Accepted 27 January 2019
⁎ Corresponding author.
E-mail addresses: mtdd1@waikato.ac.nz (M. Daoud), michael.mayo@waikato.ac.nz (M. Mayo).
Artificial Intelligence In Medicine xxx (xxxx) xxx–xxx
0933-3657/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Please cite this article as: Maisa Daoud and Michael Mayo, Artificial Intelligence In Medicine, https://doi.org/10.1016/j.artmed.2019.01.006
highlighted computational biology problems in a way that is accessible
to machine learning researchers.
The rest of the paper is organized as follows. In Section 2 we present
a basic background to neural networks and cancer prediction models.
Section 3 presents our methodology including a review of the most
commonly used neural network models for preprocessing, filtering,
prediction and clustering gene expressions. Section 4 summarizes the
reviewed studies. The discussion is presented in Section 6 and the
conclusion in Section 7.
2. Background
This section presents a basic introduction to neural networks and
cancer prediction models.
2.1. Neural Networks
Neural networks are powerful tools capable of solving non-linear
complex problems and discovering universal input–output mappings
[46]. To get a better understanding of the concept, consider a fully
connected feedforward Multi-Layer Perceptron (MLP) network with L
layers ordered as: input layer, a sequence of hidden layers, and an
output layer. The layers are indexed as l={0, . . . , L−1} and each
layer has a number of neurons equal to nl. We will denote each input
training example x as I x I I I( ) [ , , ..., ]n1 2 0= and its output
O x O O O( ) [ , , ..., ]n1 2 L 1= .
The network is trained by feeding the inputs forward to calculate
the activation value for every neuron. At the output layer, neuron ac-
tivation values are calculated and aggregated to get O(x).
The difference between O(x) and a desired output, i.e. the error, is
calculated using a predefined objective function. Using a back-
propagation algorithm, the objective function is optimized by propa-
gating the error derivatives back through the network to fine-tune the
weights for optimal error value. The discussed feed forward layered
networks and backpropagation mechanism are one of the most com-
monly used architectures and training algorithms. We focus on them as
they are widely used with gene expression data. Prieto et al. [58]
presented a comprehensive overview of modelling, simulation and
implementation of neural networks with some examples to models used
for solving real-world problems.
In the next sections, we review previous works proposing neural
network-based cancer prediction models. These models adopt the MLP,
convolutional neural network or generative adversarial network ar-
chitectures for learning the gene expression features. All methods use a
similar training algorithm to the one described above with some dif-
ferences in the number of neurons and networks architectures.
Convolutional neural networks [47], for example, perform feature ex-
traction by scanning a set of weight matrices across the input; these
weight matrices learn to recognize the relevant patterns. Another ex-
ample is generative adversarial networks [59] which consist of a gen-
erative network and a discriminator network. The generative network
learns to generate output samples, given random noise as input, while
the discriminator network learns to discriminate the true data samples
from the generated fake data samples.
2.2. Cancer prediction models
Cancer is a serious worldwide health problem usually associated
with genetic abnormalities. These abnormalities can be detected using
microarray techniques which measure the expression and the activity of
thousands of genes. Generating a microarray involves hybridizing two
DNA strands collected from two samples, e.g. diseased and healthy
tissues. Each of these samples is originally a reverse transcript of mRNA
and labeled with a dye. The two samples are mixed into a single mi-
croarray and scanned with an appropriate source of light to provide an
image with an array of features. The intensity of each spot or the
average difference between matches and mismatches can be related to
the amount (expression) of the mRNA presents in the tissue, i.e the
amount of protein produced by the gene corresponding to the given
feature. The ultimate goal of this genomic analysis technology is to get
better insight into the disease and to improve cancer diagnosis [5].
Cancer prediction models consist of one or more methods working
collaboratively to achieve high prediction accuracy. Statistical and
machine learning methods have been widely used for building cancer
prediction models that help physicians to provide more accurate
prognosis, individualized treatments, and reduce the cost per patient.
The accuracy of cancer prediction models is affected by the char-
acteristics of the input data. Gene expressions are high dimensional and
include irrelevant noisy features which degrades classification accu-
racy. They also exhibit spatial structure and, hence, incorporating in-
formation about this may increase the model's discriminating ability
[68].
The predictive performance of cancer prediction models can be
measured by different metrics such as the accuracy, recall, specificity,
precision, negative prediction rate, Matthew correlation coefficient and
F1 (shown in Table 1). Receiver Operating Characteristic (ROC) curve
[29] is another measure represented as a plot of the true positive
(sensitivity) rate against the false positive rate (specificity) [38,18]. It
reflects the probability that a classifier will rank a randomly chosen
positive instance higher than a randomly chosen negative one. A good
prediction model is the one achieving good balance between sensitivity
and specificity [18]. Statistically, this corresponds to ROC ≥0.7 [18].
However, the ROC value should be paired with the confidence interval
value to test its validity.
Survival analysis is a different field concerned with predicting the
time until a medical condition occurs. From a machine learning per-
spective, survival analysis is a ranking problem in which data points are
ranked on their survival times rather than predicting the actual survival
times [64]. The Concordance Index (CI) is one of the standard perfor-
mance measuring tools for assessing the quality of ranking in survival
analysis studies. CI can be interpreted as the probability of concordance
between the predicted and the observed survival where a value close to
0.7 indicates a good model and a value close to 0.5 means random
concordance. Brier score is another metric measuring the mean of the
difference between observed and estimated survival over a certain time.
Brier score ranges between 0 and 1 and a larger score indicates higher
inaccuracy [12].
3. Neural network-based cancer prediction models
An extensive search relevant to neural network-based cancer pre-
diction was conducted using Google scholar and two other electronic
databases namely PubMed and Scopus. Search was performed using
keywords such as “Neural Networks” AND “Cancer classification”,
“Neural Networks” AND “Gene expressions”, “Neural Networks” AND
Table 1
classification metrics, TP is true positive, TN is true negative, FP is false positive
and FN is false negative.
Metric name Definition
Accuracy TP TN









Negative Prediction Rate TN
TN FN+
Matthews Correlation Coefficient (MCC) TP TN FP FN
(TP FP)(TP FN)(TN FP)(TN FN)
× ×
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“Microarray”, “Neural Networks AND Cancer Prediction” and “Neural
Networks AND gene expression clustering”. Only articles published
between 2013–2018, publicly available for free, and including one or
more neural network models in their approach were considered. The
chosen papers covered cancer classification, discovery, survivability
prediction, and statistical analysis models. Papers using imaging or text
(record) inputs were excluded.
Fig. 1 shows a graph representing the number of citations for each of
the considered papers. We grouped the papers according to their
functionality and ordered them chronologically by the year of pub-
lication. Considered papers have reasonable number of citations ranges
between 5–120, however, papers published by 2018 are the least cited
ones, some of them have zero citation, but they were considered to
present some state-of-the-art approaches in the field.
In the next subsections, we review the chosen papers by presenting
the adopted preprocessing techniques and the proposed models con-
figuration.
3.1. Datasets and preprocessing
Most studies investigating automatic cancer prediction and clus-
tering used publicly available datasets such as the TCGA [70], UCI [22],
NCBI Gene Expression Omnibus (GEO) [55] and Kentridge biomedical
[39] databases. These repositories were used by [20,69,51,37],
[85,51,7], [85,14,15,37] and [43] respectively. In rare cases such as
[9,50], studies are conducted using a specific dataset that was collected
and prepared for a problem under investigation.
Removing the genes that have zero expression value across all
samples is one of the simple and most straight forward preprocessing
technique and is used by [20,84,12]. Chaudhary et al., [12] followed
this step with removing the samples that have 20% of the features re-
moved.
Normalization is also an essential technique in some cases. MAS5.0
affymatrix normalization was used by [69,15,14]. Mapping to Entrez
Gene ID and averaging were used by [85]. Fragments per kilobase per
million (FPKM) normalization was used by [76]. Funnorm normal-
ization to remove the unwanted technical variation in methylation ar-
rays and filtering with p value > 10−05 was used in [69]. Datasets
should be also normalized for training purposes using methods such as
the zero mean one unit variance normalization which was used in
[74,44,12]. Other kinds of transformations such as log-fold change
transformation and log2 transformations can be also used such as in
[50] and [12] respectively.
Different techniques were adopted to reduce the dimensionality of
the gene expressions by selecting a subset of genes. Statistical methods
were applied by [20,74]. Choosing a subset of related genes as in-
dicated by other studies or data repositories such as the Online Men-
delian Inheritance in Man (OMIM) [35] is another simple feature
selection technique adopted by [15,14,51]. Chen et. al, [15,14] applied,
in both of their studies, the same preprocessing methods including Chi-
square feature selection, selecting the top-10 ranked lung cancer-re-
lated gene signatures and combining them with T-stage and N-stage
clinical data. Instead of selecting a subset of genes, Tan et al. [67] set
the expression of a randomly chosen number of genes to zeros. Xiao
et al. [76] applied the DESeq method to select a set of differentially
expressed genes, most informative genes, based on their read count.
Even though neural networks are used for extracting the datasets
features by reducing the dimensionality of the data, Principle
Component Analysis (PCA) can be used as an initial preprocessing step
[28,85]. The PCA method linearly transforms the dataset features into a
lower dimensional space without capturing the complex relationships
between the features. Therefore, a good technique can be adopted by
merging the PCA components with a random number of raw features to
allow the networks to capture further useful relationships [28,85].
In cases where researchers are interested in studying datasets from
different sources such as [85,67]. Dataset features can be forced to have
the same dimensionality for training and testing purposes, Zhang et al
[85] padded the features with zero values, but this technique might
increase the sparsity of the data. However, [67] overcame the problem
by simply removing the genes that were not measured by the other
datasets.
The class imbalance problem has only been considered once by [20]
who used Synthetic Minority Class Over Sampling (SMOTE) method to
generate synthetic minority class samples. Liu et al. [49] had con-
sidered the problem of small sized dataset and proposed an over-
sampling technique that simply duplicates 20% of the data and used it
for training. The duplication rate was proportional to the dimension-
ality of the data and, to force variability in the generated samples, they
set a number of randomly chosen features into zeros. However, this
technique can lead to sparse matrix problem.
Clustering was also applied in some studies for labeling the data by
grouping the samples into high-risk, low-risk groups, or more [14]. In
[84] a clustered gene filtering technique was used based on the muta-
tion occurrence frequency of the gene data and to reduce the sparsity
and the dimensionality of the data they proposed indexed sparsity re-
duction (ISR) procedure (see [84] for detailed description of both
methods).
Table 2 presents the dataset used by each of the considered refer-
ences, the applied normalization technique, the cancer type and the
dimensionality of the datasets.
3.2. Neural network architecture
Our analysis to the most recent studies reveals that neural network
methods have been used, in cancer prediction models, for: (i) filtering
the gene expressions by removing their noise or reducing their di-
mensionality. The resulted features are used with statistical methods or
machine learning classification and clustering tools such as decision
trees, K Nearest Neighbor (KNN) and Self Organizing Maps (SOM) (see
Fig. 2). (ii) predicting methods which extract the features that increase
the prediction (classification) accuracy. These methods combine both
the dimensionality reduction with the prediction goals in the same
learning algorithm, and (iii) Clustering methods which divide gene
expressions or the samples, based on their similarity.
It is important to note here that all neural network's neurons work as
feature detectors (filters) that learn (extract) the inputs’ features.
However, our categorization into filtering, predicting and clustering
methods was based on the overall role that a neural network performs
in the cancer prediction model. Filtering methods are trained to remove
the input's noise and to extract the most representative features that
best describe the unlabeled gene expressions, so the used learning ob-
jective function has no direct relation with prediction. Nevertheless,
predicting methods are trained, using labeled inputs, to extract the
Fig. 1. Number of citation for each of the considered datasets.
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features that are significant to prediction, so its objective function
measures how accurately the network is able to predict the class of an
input. Clustering methods are trained using unlabeled samples to divide
them into groups based on their similarities.
3.3. Building neural networks-based approaches for gene expression
prediction
This section surveys a group of recently published studies to high-
light the basic role that neural networks perform in cancer prediction.
Our classification of the studies was based on investigating the learning
algorithm, the objective function and its relationship with the predic-
tion goal.
Based on our investigation of the related studies and categorization
to the networks into filtering methods, prediction methods and clus-
tering methods. We found that filtering methods learn how to generate
representative codes with dimensionality M≤N (where N is the di-
mensionality of the input) that can be used with other machine learning
Table 2
Datasets and Preprocessing. Dimension column shows the number of features× samples used for prediction, “-” indicates a missing value.
Dataset Reference Normalization Cancer type Dimensions
[33] [25] AML - 7129×46






TCGA, GEO and others [37] - Prostate 15×466
TCGA [69] Funnorm Breast 300, 000× 862
GEO [85] MAS 5.0 Breast 881× 13698+69/75



































home made [50] - Breast 21×222
TCGA [84] - 12 different cancer 3122×22, 834










































































TCGA [14] MAS5 lung 14×280
GEO [51] - lung 15×107
TCGA [15] MAS5 lung 14×280








93 × 7129 93
642× 15154
home made [9] - bladder 10×104
Fig. 2. Neural networks for filtering the gene expressions in cancer prediction
models.
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algorithms such as naïve Bayes and k-means for prediction or clustering
purposes. These methods can be proceeded with preprocessing
methods, but used to apply further processing on the data and learn in a
purely unsupervised way with no direct relationship with prediction
(Fig. 2). Predictive neural networks are trained using a supervised
learning algorithm to maximize classification accuracy. Clustering
methods, on the other hand, are trained using an unsupervised algo-
rithm to set similar samples or genes in groups (Fig. 3). prediction and
classification approaches are usually proceeded by dimensionality re-
duction methods but the goal of training them is to increase the net-
work's capability to classify or to find the most similar group to a new
testing instance with unknown label respectively.
3.3.1. Neural network filters for cancer prediction
There is a growing interest in using autoencoders to extract generic
genomic features in a preprocessing step to classification, clustering and
statistical analysis [24,32,23,72]. The autoencoder, in its simplest form,
consists of three layers: input layer, hidden layer and output layer, di-
vided into two parts: the encoder part to learn the mapping between
high-dimensional unlabeled input data I(x) and low-dimensional re-
presentations (in the bottleneck layer), and the decoder part which
learns the mapping from the middle layer's representation to the high-
dimensional reconstructed output O(x). More complicated deep archi-
tectures are built by adding more hidden layers to both halves of the
architecture.
Autoencoder-based approaches learn how to reconstruct the input
examples by optimizing an objective function such as the Root Mean
Squared Error (RMSE) (shown in Eq. 1):
I x O x
n
RMSE
( ( ) ( ))2
=
(1)
or the Logloss function (Eq. 2):
I x O x I x O xLogloss ( ( )log( ( )) (1 ( ))(log(1 ( ))))= + (2)
where the number of neurons at the input layer n0 equals to the number
of neurons at the output layer nL−1 and L is the total number of layers.
Different types of autoencoders such as stacked denoising auto-
encoders used by [67,20], contractive autoencoders [50], sparse auto-
encoders [28], regularized autoencoders [12] and variational auto-
encoders [69,74] have been recently used for filtering microarray gene
expressions (see Table 3). The architecture of the networks varied in
depth (shallow and deep architecture), loss function and other para-
meters. A single hidden layer architecture and sigmoid activation
function was used in [28,67]. Tan et al. [67] used a cross-entropy si-
milarity function and stochastic gradient descent optimization. In 2016,
Danee et al. [20] used a deep architecture of four layers (15,000,
10,000, 2000, and 500 neurons respectively) with stochastic gradient
descent optimization algorithm. Both Way et al. [74] and Titus et al.
[69] used the same variational autoencoder consisting of three hidden
layers; two of the layers were in the same hierarchal level such that they
receive their inputs from the input layer and send their activations
forward to the third hidden layer in the higher level of the network.
Titsu et al. [69] used the same implementation used by [74] except that
they adapted the model to take 300,000 inputs instead of 5000. Both
studies set the batch size to 50, learning rate to 0.0005 and epochs to
50. A simple network of two stacked hidden layers (500, 100 neurons)
autoencoder was used in [12] and trained for 10 epochs. Zhang et al.
[85] used an interesting yet simple approach for predicting the clinical
outcomes of breast cancer patients. They used two hidden layers (64, 32
neurons) and added a number of neurons to the input layer which has
13698 neurons for the PCA components which were extracted in a
preprocessing step. The layers were activated with the exponential
linear unit activation function and optimized using Adam optimizer for
backpropagation. Learning rate was set to 0.001, batch size 64, epochs
10000 and each layer was initialized with uniform distribution. Note
that we are counting the number of hidden layers in the encoder side.
The decoder part is a reflection to the encoder.
Overfitting is one of the major challenges affecting the efficiency of
the extracted features. To overcome this problem, Chaudhary et al. [12]
used regularization technique. Dropout was used by [20,12], and
[28,85] added sparsity penalty to the similarity functions.
However, the autoencoders features were used by different statis-
tical methods and classifiers to solve both binary and multi-class clas-
sification problems. [28] applied softmax regression for binary classi-
fication. Macias et al. [50] applied Cox regression model analysis and
showed that autoencoders are valuable statistical tool for noise reduc-
tion in breast cancer data. They indicated that this result could be
generalized for other biomedical data. Danee et al. [20] used Support
Vector Machine (SVM) and a shallow neural network classifier with a
softmax layer to classify the breast samples into two classes. K-means
clustering was used in [12] and results showed that clustering the re-
sulted autoencoder features into 2 clusters was the best to give op-
timum survival analysis results. They next used the resulting two
clusters as labels to build an SVM classifier. Results demonstrated that
using cluster labels is robust to predict survival-specific clusters better
than the PCA extracted components. The overall performance was
measured using CI and Brier error values tools. Zhang et al. [85] used
an AdaBoot classifier to classify breast cancer patients into good
prognosis and poor prognosis groups according to whether distant
metastasis had occurred within 5 years or not. [69] applied t-SNE on
the extracted representations for further dimensionality reduction to 3-
D, 2-D and 1-D spaces. Logistic regression using a “one v.s rest” multi-
class approach was used for subtype cancer classification and results
showed that the 3-D features were significantly better than the others.
Tan et al. [67] applied sample characteristics classification, transcrip-
tion factor enrichment, survival analysis, and pathway analysis both on
binary and multi-class levels. In [67] the author tested the performance
of independent hidden nodes in discriminating tumors from normal
samples and in [20] they used another simple neural network classifier
consisting of an input layer connected directly to an output layer and
compared its performance with an SVM. Most of the studies used 10-
fold [28,67,12] and 5-fold [20] cross validation for estimating the
classification error.
To conclude, neural network filtering methods were used for three
different purposes: (1) to learn low dimensional representations; (2) as
a transformation function that removes the noise from the input, and
(3) to initialize a neural network classifier by replacing the auto-
encoder's output layer with a new output layer and re-training the
classifier using the previously learned weights and biases, this leads to a
better generalization performance. Table 3 lists the type of the auto-
encoder used by each reference, overfitting elimination technique, the
number of hidden layers, the predictor type (classification/clustering
algorithm), the number of classes and the used evaluation metric.
3.3.2. Neural networks prediction methods for cancer prediction
Neural network-based prediction (classification) involves building a
network that maps the input features to an output with one or two
Fig. 3. Neural networks for predicting or clustering the gene expressions in
cancer prediction models.
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neurons (binary classification) or multiple neurons (multi-class classi-
fication). A different approach for solving the multi-class classification
problem is by using multiple independent binary neural networks.
However, a predictive network can be configured using an input layer,
one or more hidden layers and an output layer with nL−1= k where k
equals to the number of classes that the training inputs belong to.
Before training, a binary string C k of length k (called the “codeword”)
is assigned to each training example such that the codeword for the j-th
class is assigned by setting the bit in the codeword at the j-th position
equals to 1, and the remaining bits to 0. For example, a 4-class problem
can be modeled by assigning the (0,0,1,0) codeword to all training
examples belonging to the third class of the problem, this technique is
called “one-hot encoding”.
A neural network can learn by feeding the labeled (or coded) inputs,
calculating the neurons activations and passing them forward through
the network. At the output layer, the activation function sums together
the contributions of all sending units. This sum is then further modified
by adjusting the activation sum to a value between 0 and 1 (in binary-
class problems) or by setting the activation value at a specific position
to zero unless a threshold level is reached. Through this process, the
network iteratively learns the mapping between each input example I
(x) and its class codeword by minimizing an objective function such as
the Mean Squared Error (MSE) (Eq. 3). In the testing phase, a sample is
assigned to the j-th class if the network output C k (predicted class) at
the j-th position has the highest confidence value.
E C x C xMSE [ ( ) ( )]j j 2= (3)
Hence, the MSE estimates the posterior probability function for the
classification problem.
Neural network-based cancer classifiers have been used with both
binary-class and multi-class problems to identify cancerous/non-can-
cerous samples, a specific cancer type, or the survivability risk.
Our analysis revealed that the architecture of the recent predictive
neural networks range between deep MLP models [14,51,84,37] and
single-layered networks [15,7,43,25]. In 2014, Chen et al. [15] pre-
dicted the survival risk of lung cancer patients. The decision on the
model configuration was made based on trail-and-error and best results
achieved with one hidden layer and eight hidden nodes. The input to
the neural network was formed by combining six gene expressions, T-
stage and N-stage data to form 14-D inputs. The approach achieved
high prediction accuracy in classifying the patients into low-risk and
high-risk groups. The same MLP model was adopted by Chen et al. [14]
in 2015 to improve the accuracy of lung cancer survival multi-class
prediction where patients were classified into five classes (very low,
low, normal, high and very high). Labels were assigned to the samples
using a clustering technique in a preprocessing step. The network was
used to learn these labels and tested in terms of its ability to predict the
survivability class of new testing samples. The model achieved superior
classification accuracy compared to Bayesian network, SVM, and K-
Nearest Neighbor (KNN).
Mandal and Banerjee [51] used another MLP network and experi-
mentally tested the model using two different datasets for breast and
lung cancer. Only the results of the latter dataset are considered in this
review, as the former consisted of 10 non-genome features. Mandal and
Banerjee [51] used 15 genes that are responsible for the lung cancer, as
indicated by an earlier study [52]. The best accuracy level (94.0%) and
was achieved when the number of hidden layers was 3.
In 2016, Bhat et al., [7] suggested a deep generative model called
Table 3
Neural network filtering methods used in cancer prediction models.
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DeepCancer for binary (cancerous/non-cancerous) classification.
DeepCancer uses a convolutional GAN with an input dense layer, four
hidden layers in the generator side, three hidden layers and an output
layer with two hidden nodes in the discriminator side. Interestingly,
Bhat et al. [7] also used two other RBM-based regression models, called
RBM-SVM and RBM-logistic, as baselines. In both models they used one
hidden layer and experimented different number of hidden nodes to get
the best classification precession. No feature selection method was
applied before classification, and the average performance of Deep-
Cancer was better than the baseline models. This indicates that the
generator learned how to accurately represent the features of the da-
tasets.
DeepGene [84] is a convolutional feedforward model for somatic
point mutation-based cancer type classification. DeepGene's approach
includes converting the gene data into indexes of its non-zero elements
using Indexed Sparsity Reduction (ISR), and feeding the output into a
deep neural network classifier. The approach was tested on classifying
twelve types of cancers and compared with other machine learning
approaches such as SVM, KNN and naïve Bayes. The model achieved the
best level of accuracy when using four hidden layers, ReLU activation
function, softmax output layer and logarithmic loss function.
A new approach was suggested by [43] using Extreme Learning
Machines (ELM). ELM utilizes the concept of generalized single hidden
layer feedforward neural networks. In this network, neurons are gen-
erated using an analytical approach so the hidden layer does not require
any tuning. The model was tested using five diseases framed as binary
class problems. The correlation coefficient mechanism was used to se-
lect 2-4% relevant genes and the model achieved high classification
accuracies.
Convolutional networks are most commpnly used with images da-
tasets, however, [49] introduced one dimensional convolutional fra-
mework that is applicable with the 1-D gene expression dataset. The
model, named SE1DCNN after the sample expansion method used to
oversample the training split of the data and the 1-D convolutional
model which consists of 7 layers (input, 2 convolutional layers, 2 max
pooling layers, one fully connected layer and an output layer)
Dwivedi [25] compared the performance of six machine learning
classifiers including: neural networks, SVM, logistic regression, naïve
Bayes, classification trees and KNN, in classifying a lukemia dataset into
two groups. He used an MLP architecture (one hidden layer with 20
neurons, 30 epochs) and proved that neural network outperformed
other considered classifiers. No preprocessing, filtering or feature se-
lection was applied on the 6817 genes which were obtained from a
previous study [33].
Hou et al. [37] integrated genetic algorithms with artificial neural
network in a model called GA-ANN. The model consisted of 3 layers,
1000 nodes as the input layer, and one node in the output layer. The
learning rate was 0.1 and the goal was to classify the clinical phenotype
into binary groups. The role of the genetic algorithm was to select the
best number of input variables that maximizes the classification accu-
racy. The population size for the genetic algorithm was set to 100, the
maximum evolutionary generations was 50, and the algorithm selected
15 candidate input variables.
Xiao et al. [76] applied deep learning to an ensemble approach that
incorporates five different machine learning models. Informative gene
selection was applied on differentially expressed genes. Then, a deep
learning method was employed to ensemble the outputs of the five
classifiers KNN, SVM, decision trees, random forests, and gradient
boosting decision trees. The model of five hidden layers was used for
binary (tumor/normal) classification hence one output unit was used in
the output layer, ReLU activation functions and SGD optimizer was
used to minimize the MSE similarity function; regularization, to con-
strain the magnitudes of the weights, was added to the function to
overcome the overfitting problem. This paper used neural networks for
discovering the relationship between the 5 different classifiers which
were used to classify the training sample into tumor/normal class. The
approach built a new dataset consisting to m×5 items where m is the
number of training samples and 5 denotes the binary label predicted by
a specific classifier. The new dataset was used as input to the neural
network model to avoid using the weighted averaging and majority
voting algorithms which is widely used in general ensemble strategies.
Table 4 lists the models’ name, reference, the type of the used neural
network, overfitting technique, the number of hidden layers, and the
number of classes i.e. the number of output layer's nodes and the used
evaluation metric. The researchers experimentally tested different
neural network configurations and parameters but we only listed the
number of hidden layers that achieved best results. We also listed the
number of nodes in the output layer to indicate the category of the
problem (binary-class/multi-class). We want to note that some of the
listed, parenthesized, approaches have been used as baselines for
comparison purposes and we considered them here to show their con-
figuration.
3.3.3. Neural network clustering methods in cancer prediction
Clustering is an unsupervised learning technique which divides the
input data examples based on their feature similarity into groups.
Neural networks, particularly SOM, are traditional model-based
clustering techniques that are widely used with gene expression data.
SOM [41] is a single-layered neural network projecting high dimen-
sional data inputs onto a grid space. SOM's output layer neurons are
organized in a two or three-dimensional map where each neuron re-
presents a cluster and similar clusters are placed near each other using a
simple neighborhood function. SOM associates each of its output neu-
rons with a reference vector, learned during training, and each data
Table 4
Neural network predicting methods used in cancer prediction models.
Model name Reference Neural network type Overfitting No.layers No. hidden nodes No.output Metric
MLP [76] MLP regularization 5 - 1 AUC
MLP [25] MLP - 1 20 1 F1
GA-ANN [37] MLP - 3 - 1 AUC







[7] convolutional GAN - 7 - 2 Precesion
recall
F1




[14] MLP - 1 8 2 Acccuracy
sensitivity
specificity
MLP [51] MLP - 3 - 1 accuracy
MLP [15] MLP - 1 8 5 accuracy
ELM-based classifier [43] ELM - 1 - 1 accuracy
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point is mapped to the neuron with the closest reference vector.
SOM learns using a pure unsupervised algorithm with unlabeled
data and without backpropagation mechanism. Its accuracy can be
measured using various evaluation matrices such as the Rand Index (RI,
defined by Eq. 5) which is one of the most commonly used techniques to
asses clustering in gene expression datasets. [81,83].
RI TP TN
TP TN FP FN
= +
+ + + (4)
Adjusted Random Index (ARI) and Normalized Mutation Information
(NMI) are improved variations of RI metric, equations can be found in
[83].
In terms of cancer related applications, clustering is an analysis tool
used to divide the samples or the genes into groups. Generally, gene
expression clustering approaches separately group the genes or the
samples by either considering the relevance, probability, of a sample
belonging to a cluster (samples-to-cluster assignment) or the relevance
of a gene belonging to a cluster (gene-to-cluster assignment). However,
recent approaches tried to improve the quality of clustering by taking
both kinds of assignments into account.
The high dimensionality of gene expression samples is a problem
facing clustering algorithms. Traditional clustering techniques such as
k-means separate the samples (or genes) based on a distance function
but this approach is not suitable for high dimensional datasets as the
distance between the samples is isometric [65]. Neural network-based
approaches are able to discover sample-cluster mapping and, conse-
quently, they improve clustering accuracy. However, these methods
may suffer from noisy genes and improper setting of parameters. Two
solutions have been suggested to overcome the high dimensionality
problem: (i) clustering ensembles by repeatedly running a single clus-
tering algorithm such as SOM or Neural Gas (NG) with different in-
itializations or numbers of parameters, and (ii) projective clustering by
only considering a subset of the high dimensional features.
In 2014, Borkowska et al. [9] evaluated the molecular events that
characterize high- and low-grade bladder cancer pathways in bladder
cancer patients. Low-grade and high-grade tumors are two distinct
pathways of urothelial carcinogenes resulting from the deletion and
mutation of some markers. However, many tumors have mutual aspects
of low- and high-grade biology. The aim of the study was to dis-
criminate future tumor behavior using molecular alterations. The au-
thors collected samples from 104 random patients and measured the
expression of ten genes which were proved to be related to bladder
cancer as indicated by previous studies. The number of the network's
inputs was ten and the output was set to two-dimensional grid of 16
(4× 4) neurons. SOM was compared to other statistical methods and
proved its ability to group the patients into 4 groups, each of which
consisted of 4 clusters namely X1, X2, Y1, Y2. Patients with the worst
prognosis were set in X1 group. The highest abnormal TP53 expression
and heterozygocity loss for 9, 13 and 17 chromosome loci were grouped
in X2. Samples with negative UroVysion test and high FGFR3 mutation
ratio were grouped in Y1 and the ones with positive UroVysion test and
had FGFR3 gene mutation were grouped in Y2. These results were hard
to be obtained using classic statistical models which require explicit
assumption of certain relationships within the data that are often un-
proven.
In 2015, Yu et al. [83] introduced two ensemble clustering frame-
works, respectively, Random Double Clustering-based Cluster En-
sembles (RDCCE) and Random Double Clustering-based Fuzzy Cluster
Ensembles (RDCFCE). Both frameworks select a basic clustering algo-
rithm such as SOM or NG to project high dimensional genes into a low
grid dimension. As a result, a set of representative features, corre-
sponding to the centers of the clusters, is generated. A new dataset is
generated after that based on a subset of representative features and the
process repeats for a specific number of times to get a number of
clustering solutions B. A consensus matrix is then constructed using the
set of clustering solutions C′1, C′2, . . . , C′B. Finally, a normalized cut
algorithm [52] is used to partition the consensus matrix, and obtains
the final result. Both RDCCE and RDCFCE work in the same way except
that RDCFCE extends the model by incorporating the fuzzy algorithm to
improve the performance of the framework. The models achieved high
accuracy clustering results but they only considered sample-to-cluster
assignment and ignored the gene-to-cluster assignment. Clustering
performance was measured by RI and Purity measure (more details are
provided in [83]).
As shown by Table 5, Yu et al. [83] also used another neural net-
work-based clustering approach as a baseline which is: (i) double SOM-
based Clustering Ensemble Approach (SOM2CE) [82] and (ii) double
NG-based Clustering Ensemble Approach (NG2CE) [13]. Both obtain
satisfactory results on most testing datasets and proved that they are
robust to noisy genes.
In 2017, Yu et al. [81] suggested Projective Clustering Ensemble
(PCE), which combines the advantages of both projective clustering and
ensemble clustering, and they compared its performance with a set of
clustering techniques including SOM and RDCFCE. Experiments on
synthetic datasets showed that the accuracy of SOM decreases with the
increase of injected noise. This indicates that SOM can not distinguish
clusters in the presence of noisy genes. Results also showed that the PCE
outperformed the RDCFCE as it assigns the irrelevant genes weight that
explicitly reduces the interference.
4. Summary
Cancer is a world wide genetic-related disease which imposes sig-
nificant mortality and cost. Analyzing gene expression data is essential
for discovering genes abnormalities and increasing survivability as a
consequence.
Neural network methods are the backbone of most recent cancer
prediction models. Their ability to discover complex input-output re-
lationships assists in obtaining more accurate sample-class (or sample-
cluster) assignments than using the traditional machine learning tools
which relays on distance functions or statistical assumptions. Our
analysis to the most recent research in gene expression analysis tools
and cancer prediction models reveals that neural networks are essen-
tially used for filtering the gene expressions, predicting their class, or
clustering them.
Neural network filtering methods, more specifically the auto-
encoders, were used as data engineering methods in a prior step to
prediction. Examples of autoencoder-based approaches are contractive
autoencoders, regularized autoencoders, sparse autoencoders and
stacked denoising autoencoders which was the most widely used one.
Most of the suggested filtering approaches have been experimentally
tested using shallow architectures. However, deep architectures are
Table 5
Neural network clustering methods used in cancer prediction models.





























SOM [9] SOM 16 -
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more recommended for best practice as they combine many non-line-
arities. On the other hand, it has been proven that shallow networks are
inefficient in terms required training examples and the number of
hidden nodes [6].
The extracted features have been used to train different machine
learning tools such as SVM [20], neural network classifiers [80], k-
means clustering [12] or statistical analysis [50]. Generally, filtering
methods were used to reduce the dimensionality of the gene expres-
sions, to transform the gene expressions into a different form, with the
same length, or to learn gene expressions’ representations and use the
learned weights and biases to initialize a predicting network.
Neural network prediction methods have been used for both binary
and multi-class problems. In binary problems, the classifier learns how
to diagnose a given sample as cancerous, or non-cancerous or to dis-
criminate one type of cancer from another. In this case, the network
architecture can only have one [43,42] or two [7,14] output neurons in
its output layer. In multi-class problems the network learns how to
discriminate between multiple types of cancer or to predict the survi-
vability risk; so the network's output layer has a number of neurons
equal to the number of classes that the training data belong to [84], or
alternatively multiple binary classifiers can be used. However, the de-
cision on the number of hidden layers and nodes is usually made based
on trail-and-error technique. Statistical preprocessing have been also
applied in some cases [14]. Deep architecture with convolution layers
was the most recently used model, especially with multiclass problems,
and proved efficient capability in predicting cancer subtypes as it
captures the spatial correlations between gene expressions. However,
full Details on the networks configuration, overfitting elimination
technique and learning parameters were not provided in most studies.
Results generally show that neural network-based approaches out-
performed other machine learning tools in classifying gene expression
samples in most of the studies.
Clustering is another analysis tool that is used to divide the gene
expressions into groups. Neural network-based clustering approaches
have been applied as an alternative to traditional clustering techniques,
which use a distance function to measure the similarity between gene
expressions. Nevertheless, neural network approaches such as SOM and
NG are not able to distinguish the noisy genes, so samples are clustered
based on both the relevant and irrelevant genes. Ensembling clustering
and projective clustering are two general approaches suggested to
overcome the high dimensionality related problems. A hybrid approach
combining both the ensembling clustering and projective clustering,
such as [81], has proved higher accuracy than using single-point clus-
tering algorithm such as SOM.
Considered studies used different preprocessing techniques, data-
sets, analysis and classification tools and they were used to solve dif-
ferent problems (binary and multi-class classifications). These differ-
ences make the decision on the best network configuration and
performance hard to be made and unfair. This was also noted by [66]
who indicated that there is no machine learning algorithm consistently
outperforms any of the other as the nature of the dataset seem to be of a
major influence on the performance of the algorithm. There is an op-
portunity here for a future work to develop a ”benchmark” toolkit for
gene expression data mining so that modern NN algorithms can be
compared in a uniform way. However, we are discussing in the next
section some practical issues that can be considered for future models.
5. Discussion
In this paper, we reviewed recent works on neural network based
cancer prediction models. Here we discuss some technical problems
that can be considered for building new models.
Overfitting: gene expression datasets are high dimensional and have
a relatively small number of samples. While most of the studies on
cancer prediction models focused on learning good representations that
increase the models predictability, some ignored the problem of
overfitting which is caused by using small number of training examples
as indicated by [63]. Overfitting problem occurs when the network is
over trained on the training examples so it properly fits the training
examples but not the validation and the testing examples due to the
lack of generalization capability. Overfitting can be avoided by: (i)
adding weight penalties using regularization; (ii) models combination
by averaging the predictions from many models trained on different
datasets; (iii) dropout [63].
Model configuration and training: choosing neural network con-
figuring and setting its parameters is a crucial issue for extracting good
information that achieve high prediction accuracy. While there is no
rule of thumb for setting the networks parameters, there are some re-
commended issues that can be considered to reduce both the compu-
tational and memory expenses for better performance such as: (i)
proper initialization: poor initialization cause slow convergence, local
minima and model uncertainties problems [1]. (ii) pruning the unim-
portant connections by removing the neurons that have zero values.
Pruning is a good approach for reducing the memory and computa-
tional complexities. (iii) using ensemble learning framework by training
different models using different parameter settings or using different
parts of the dataset for each base model. (iv) class imbalance is a data-
related problem that had little to get attention to date when building
and analyzing cancer prediction models. This problem makes the clas-
sifiers biased toward the classes that has the majority of the data, and
consequently poorly classifie the samples belonging to minor classes.
Danee et al. [20] used SMOTE for dealing with class imbalance on the
high dimensional level. however, oversampling methods can be applied
to generate synthetic representations to increase classifiers accuracy.
Model evaluation: Using 10-fold and 5-fold cross validation to es-
timate the error of classifying small data size leads to severely in-
accurate conclusions as proved by [10]. Braga-Neto and Dougherty
[10] investigated, in their simulation study the performance of cross-
validation, substitution and bootstrap methods and revealed that cross-
validation displayed excessive variance and, hence, it is unreliable for
small size data. The bootstrap method proved more precise and reliable
predictability.
Study reproducibility: Reproducibility of the studies is another
important issue that has to be highlighted here. A study is reproducible
when others are able to replicate the results using the same algorithms
data and methodology. Reproducibility enhances research reliability
and requires the authors to publish the used data and to clearly docu-
ment their methodology. Researchers using genomic databases such as
TCGA [70] should at least state the query used for downloading their
experimental dataset in supplementary material.
6. Conclusion
This paper reviewed the most recent neural network-based cancer
prediction models and gene expression analysis tools. The considered
papers were published between 2013-2018 and used gene expression
datasets for cancer classification and clustering. This review presented
some commonly used architectures, datasets, and the accuracies of each
suggested model.
Analysing the considered papers indicated that neural network
methods are able to serve as filters, predictors and clustering methods.
Neural network filtering methods are used to reduce the dimensionality
of the gene expressions and remove their noise. MLP and convolutional
neural network classifications methods have been used with binary-
class and multi-class classification problems while the number of the
networks’ hidden layers and hidden nodes have been decided by trial-
and-error. A hybrid approach combining both ensembling clustering
and projective clustering is the best to achieve high clustering accuracy.
Deciding the network architecture is one of the challenges facing the
cancer prediction model designers, as there is no specific rule to guar-
antee high prediction accuracy. Most of the studies determined the
number of hidden layers and neurons based on trail and error.
M. Daoud and M. Mayo Artificial Intelligence In Medicine xxx (xxxx) xxx–xxx
9
However, this study indicated that the role of the neural network de-
termines its general architecture.
This study has summarized most recent approaches and their related
neural network architectures. We also highlighted some critical points
that have to be considered when building a neural network-based
prediction model such as overfitting and class imbalance. More pow-
erful neural network-based approaches can be suggested in future by
choosing different network's parameters or combining two or more of
the presented approaches.
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